Today PRACE announced that Dr Zoe Cournia is the recipient of the 1st PRACE Ada Lovelace Award for HPC. As a Computational Chemist, Investigator – Assistant Professor level at the Biomedical Research Foundation, Academy of Athens in Greece, Dr Cournia was selected for her outstanding contributions and impact on HPC in Europe on a global level.
Using the PRACE HPC resources and recent advances in computer-aided drug design allow us to develop drugs specifically designed for a given protein, shortening the time for development of new drugs,” says Dr Cournia. “I believe that our work is a good example of how computers help develop candidate drugs that have the potential to save millions of lives worldwide. I am honored to receive this prestigious award and hope that this serves as inspiration to other female researchers in the field.”
Dr Cournia was awarded core hours on PRACE resources as Principal Investigator for research on Mechanistic studies of the Arp2/3 complex activation and Selective inhibition of the PI3Ka E545K mutant through MD simulations, in vitro assays and SPR experiments in the 6th and 9th Project Access calls, she was also a collaborator on other projects in Nanotechnology and Clinical, Experimental Surgery & Translational Research.
Her research results were featured in the PRACE Women in HPC Magazine in an article entitled “Computers in the Fight Against Cancer”. This research focused on understanding the way in which mutant proteins cause the onset of cancer and opened up the possibility of designing drugs that can stop this process. Her work as a collaborator with Dr Paraskevi Gkeka on new designs in drug delivery was featured in the PRACE Digest 2015. This research focused on research into nanoparticle-cell membrane interactions and is making vital contributions to advancing the field of drug delivery design in biological systems.
Dr Cournia will receive the award and a cash prize at PRACEdays16, to be held May 10-12 in Prague. She will also participate in the final plenary panel on “How can we assess European competitiveness in the global HPC race?” at PRACEdays16.
